SEC Form 4 · accession 0001250853-16-000150
Kindred Biosciences, Inc. · KIN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Herbert D Montgomery
Director
Period of report
May 26, 2016
Accepted (ET)
May 31, 2016 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.14 | May 26, 2016 | A | 3,350 | A | — | May 26, 2026 | Common Stock | 3,350 | 3,350 | D |
Explanation of responses
- F1The option will vest in four equal quarterly installments following the date of grant, provided the Reporting Person is still providing services to the Issuer on the respective dates.